免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Overture骨科髌股系統

K 號:K231253 · 2023-07-07

決定日期2023-07-07
產品代碼KRR
諮詢委員會或
決定相當於

器材摘要

Overture Orthopaedics Patellofemoral System is the device name listed in this FDA 510(k) record. The listed applicant is Overture Resurfacing, Inc.. It received FDA 510(k) clearance on 2023-07-07 under 510(k) number K231253. The device is classified under product code KRR. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Overture Orthopaedics Patellofemoral System?

Overture Orthopaedics Patellofemoral System is a medical device that received FDA 510(k) clearance on 2023-07-07. The listed applicant is Overture Resurfacing, Inc.. The 510(k) number is K231253.

When did Overture Orthopaedics Patellofemoral System receive FDA 510(k) clearance?

Overture Orthopaedics Patellofemoral System received FDA 510(k) clearance on 2023-07-07, under 510(k) number K231253.

Who is the listed applicant for Overture Orthopaedics Patellofemoral System?

The FDA 510(k) record lists Overture Resurfacing, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Overture Orthopaedics Patellofemoral System?

The FDA product code for Overture Orthopaedics Patellofemoral System is KRR.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Overture Resurfacing, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:KRR)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑